Tailored Genes develops tailored lentivirus vectors for delivering precise therapeutic genes to target cells.
Tailored Genes has raised $1.0M in total funding. The most recent round was Grant. The last funding was announced in October 2025.
Tailored Genes's investors include FedDev.
Tailored Genes is headquartered in Toronto, Canada.
Tailored Genes develops tailored lentivirus vectors for delivering precise therapeutic genes to target cells.
Tailored Genes is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Tailored Genes — Funding & Investors." VCBacked, October 16, 2025, https://www.vcbacked.co/company/tailored-genes. Accessed August 14, 2026.
VCBacked. (2025). Tailored Genes — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/tailored-genes
{{cite web |title=Tailored Genes — Funding & Investors |url=https://www.vcbacked.co/company/tailored-genes |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated